Compare Adaptive Biotechnologies Corp (ADPT) vs Dell Technologies Inc (DELL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Dell Technologies Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Dell Technologies Inc trades at $450.06 (market cap $284.93B). The key difference: Dell Technologies Inc is far larger — about 70.5× Adaptive Biotechnologies Corp's market cap, and Dell Technologies Inc pays a 0.57% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | DELL | |
|---|---|---|
Market Cap | $4.04B | $284.93B |
Sector | Health | Technology |
52-Week High | $25.45 | $467.27 |
52-Week Low | $12.30 | $111.10 |
Enterprise Value | $4.10B | $304.51B |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Dell Technologies Inc
VMware is an industry titan in virtualizing IT infrastructure and became a stand-alone entity after spinning off from Dell Technologies in November 2021. The software provider operates in the three segments: licenses
Read more on DELL →
